ArticleThe Journal of clinical investigation2001

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

G Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.